Home > Animal Health & Nutrition > Veterinary Medical Devices > Johnes Disease Diagnostics Market

Johnes Disease Diagnostics Market Size

  • Report ID: GMI11588
  • Published Date: Sep 2024
  • Report Format: PDF

Johne’s Disease Diagnostics Market Size

The global Johne’s disease diagnostics market size was valued at USD 645.6 million in 2023 and is poised to grow at 5.2% CAGR from 2024 to 2032. The market is experiencing significant growth, driven by increasing awareness about the disease and its impact on livestock health and productivity.

 

Johne’s disease, caused by Mycobacterium avium subspecies paratuberculosis (MAP), is a chronic gastrointestinal infection primarily affecting cattle, sheep, and goats. As more livestock producers recognize the financial implications of infected animals, the demand for effective animal diagnostics has surged.
 

Recent data from the USDA's National Animal Health Monitoring System (NAHMS) indicates that Johne's disease affects approximately 68% of U.S. dairy herds, with economic losses estimated at USD 200 to 250 million annually. In Europe, a 2022 study published in the Journal of Dairy Science reported prevalence rates ranging from 20% to 50% in various countries. These statistics underscore the growing need for advanced diagnostic solutions in the global livestock industry.
 

Furthermore, advancements in diagnostic technologies, including PCR and serological tests, have enhanced the accuracy and speed of diagnosis. These improvements make diagnostic methods more attractive to veterinarians and livestock producers. Additionally, the increasing focus on animal welfare and sustainable farming practices has prompted producers to adopt reliable diagnostic techniques for identifying and managing infected animals. As a result, these factors collectively contribute to the expansion of the Johne’s disease diagnostics market.
 

Johne's disease diagnostics employ multiple techniques to identify MAP, including Enzyme-Linked Immunosorbent Assay (ELISA) for antibody detection and Polymerase Chain Reaction (PCR) to identify MAP DNA in fecal samples. Timely and precise diagnosis is crucial for managing disease transmission and reducing economic impacts on livestock industries.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market was valued at USD 645.6 million in 2023 and is projected to grow at a 5.2% CAGR from 2024 to 2032, driven by increased awareness of the disease and its impact on livestock health and productivity.

The PCR segment dominated with a 45.3% market share In 2023, due to its accuracy and reliability in diagnosing the disease.

The North American market was valued at USD 271.8 million in 2023 and is expected to grow at a 5.1% CAGR over the analysis period, supported by advanced veterinary infrastructure and strong regulatory backing.

Prominent companies in the industry include BioM

Johnes Disease Diagnostics Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 88
  • Countries covered: 22
  • Pages: 135
 Download Free Sample